US-POLITICS-PHARMACEUTICAL-SHKRELI

Nancy Retzlaff, chief commercial officer for Turing Pharmaceuticals LLC, waits for a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. Martin Shkreli, the controversial former pharmaceuticals boss and hedge fund manager indicted on securities fraud charges, has been subpoenaed to appear at a hearing of a House of Representatives committee on oversight and government reform looking at the prescription drug market. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)
Nancy Retzlaff, chief commercial officer for Turing Pharmaceuticals LLC, waits for a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. Martin Shkreli, the controversial former pharmaceuticals boss and hedge fund manager indicted on securities fraud charges, has been subpoenaed to appear at a hearing of a House of Representatives committee on oversight and government reform looking at the prescription drug market. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)
US-POLITICS-PHARMACEUTICAL-SHKRELI
KÖP EN LICENS
Hur får jag använda den här bilden?
kr 4,200.00
SEK

INFORMATION

Begränsningar:
Kontakta ditt lokala kontor för all kommersiell eller marknadsföringsrelaterad användning. Fullständiga redaktionella rättigheter: Storbritannien, USA, Irland, Italien, Spanien och Kanada (ej Quebec). Begränsade redaktionella rättigheter i andra områden. Ring ditt lokala kontor.
Upphovsman:
BRENDAN SMIALOWSKI / Frilansare
Redaktionell fil nr:
508393564
Samling:
AFP
Datum skapat:
04 februari 2016
Uppladdningsdatum:
Licenstyp:
Rättighetsskyddat
Releaseinformation:
Saknar release. Mer information
Källa:
AFP
Kod:
AFP
Objektnamn:
AFP_7O00P
Högsta tillåtna filstorlek:
4500 x 3002 bpkt (38,10 x 25,42 cm) - 300 dpi - 7 MB